524494:BOM
IPCA Laboratories Ltd
1.914,60 ₹
arrow_downward
-0,30%(-5,80) 1D
14. okt., 15.30.00 GMT+5.30 · INR
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for 524494...
Åbn
1.892,95 ₹
Høj
1.927,55 ₹
Lav
1.864,10 ₹
Markedsværdi
484,85 mia.
Gns. vol.
28,74 t
Volumen
8,52 t
Udbytte
0,31 %
Kvartalsvis udbytte
1,50 ₹
Ex-dato
7. aug. 2026
P/E-forhold
37,08
Højeste i 52 uger
2.039,30 ₹
Laveste i 52 uger
1.252,95 ₹
Indtægt pr. aktie
51,63 ₹
Aktier i omløb
126,35 mio.
Antal ansatte
17 t
Åbn
1.892,95 ₹
Høj
1.927,55 ₹
Lav
1.864,10 ₹
Markedsværdi
484,85 mia.
Gns. vol.
28,74 t
Volumen
8,52 t
Udbytte
0,31 %
Kvartalsvis udbytte
1,50 ₹
Ex-dato
7. aug. 2026
P/E-forhold
37,08
Højeste i 52 uger
2.039,30 ₹
Laveste i 52 uger
1.252,95 ₹
Indtægt pr. aktie
51,63 ₹
Aktier i omløb
126,35 mio.
Antal ansatte
17 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Invezz
·
for 1 dag siden
Dow Jones åbner 190 point højere, investorer ser mod bankindtjening og inflation
Invezz
·
for 20 timer siden
Dow højere, mens amerikanske aktier falder på chip-salg og blandede bankresultater
Invezz
·
for 1 dag siden
Dow lukker 198 point højere, mens amerikanske aktier ender blandet før regnskaber
Invezz
·
for 1 dag siden
Top 3 katalysatorer for S&P 500-indexet denne uge: obligationer, indtjeningssæson, CPI
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Om IPCA Laboratories Ltd